Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
3,736 articles
Amazon Gets In Tesla's Turf, Acquires Fauna Robotics To Put 'Sprout' Humanoid In Your Living Room
Amazon.com Inc (NASDAQ:AMZN) is accelerating its push into consumer robotics as it looks to expand beyond logistics and unlock new growth...
📰
Sarepta stock surges 14% on early siRNA trial data By Investing.com - Investing.com Canada
Sarepta stock surges 14% on early siRNA trial data By Investing.com Investing.com Canada
📰
Spectral AI (MDAI) Q4 2025 Earnings Transcript
Image source: The Motley Fool.Tuesday, March 24, 2026 at 5 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025
Enlivex Ltd. (NASDAQ:ENLV), a quality longevity company powered by a prediction markets treasury, reported net income of $1.23 billion and diluted...
Mercanto Holdings Inc. Reports Q2 2026 Financial Results and Provides Commercial Update on Québec Product Launches
MONTRÉAL, March 25, 2026 /CNW/ - Mercanto Holdings Inc. (TSXV:MUSH) ("Mercanto" or the "Company") today reported its financial results for the second...
Formedics Partners with The Immunobuddies to Deliver Strategic Market Expansion
BASKING RIDGE, N.J., March 25, 2026 /PRNewswire/ -- Formedics, a leading healthcare media and physician engagement company, is strategically...
Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics
SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with...
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the...
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.
Frazer and Harbinger Partner on Next-Generation Mobile Healthcare Products
Strategic partnership leverages Harbinger's plug-in hybrid chassis to electrify emergency medical response vehicles and next-generation mobile...
Why Are Super Micro Computer Shares Surging On Wednesday?
Shares of Super Micro Computer Inc (NASDAQ:SMCI) rose in Wednesday’s premarket session.
The stock is attempting a recovery following a...
📰
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
📰
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
LLY or ABBV: Which Drugmaker is Likely to Offer Better Upside in 2026?
LLY's obesity drugs fuel explosive growth, while ABBV depends on Skyrizi and Rinvoq. Let's see which drugmaker has the stronger 2026 outlook.
LLY or ABBV: Which Drugmaker is Likely to Offer Better Upside in 2026?
LLY's obesity drugs fuel explosive growth, while ABBV depends on Skyrizi and Rinvoq. Let's see which drugmaker has the stronger 2026 outlook.
LLY or ABBV: Which Drugmaker is Likely to Offer Better Upside in 2026?
LLY's obesity drugs fuel explosive growth, while ABBV depends on Skyrizi and Rinvoq. Let's see which drugmaker has the stronger 2026 outlook.
Rönesans Holding Announces New Global Partnership
Strategic Partnership Signed Between Rönesans and SJ Group to help continue to deliver the DAPEK Industrial Zone ISTANBUL , March 25, 2026...
📰
SRPT Stock Rallies After Promising Early Results For RNA Therapies Targeting Rare Muscle Diseases - Stocktwits
SRPT Stock Rallies After Promising Early Results For RNA Therapies Targeting Rare Muscle Diseases Stocktwits
📰
Sarepta (SRPT) Sees Promising Phase 1/2 Results in Neuromuscular Treatment - GuruFocus
Sarepta (SRPT) Sees Promising Phase 1/2 Results in Neuromuscular Treatment GuruFocus
📰
Jushi Holdings Inc. Announces First Settlement in Ongoing Hemp-Derived THC Litigation
BOCA RATON, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. ("Jushi" or the "Company") (CSE:JUSH) (OTCQX:JUSHF), a vertically...
📰
Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?
Assertio (ASRT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate...
📰
Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?
Assertio (ASRT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate...
📰
BeyondSpring Reports 2025 Year-End Financial Results
Plinabulin (BeyondSpring's Lead Program):
Billions in Flight: AI and Autonomous Drone Technologies Set to Disrupt Global Markets
AI-powered drones are rapidly reshaping logistics, defense, and infrastructure—unlocking a high-growth market projected to multiply several times...
📰
Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome
FDA indicated that a single Phase 3 study may be sufficient to support marketing approval in the U.S.
📰
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
Southlake, TX , March 25, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare...
📰
BeyondSpring Reports 2025 Year-End Financial Results
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"...
📰
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
Southlake, TX , March 25, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare...
📰
Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48
Earnings Driven by Treasury and Treasury-Related Asset Appreciation
📰
SEM Shareholder Buyout Investigation Launched by Kaskela Law: Does $16.50 Per Share Buyout Proposal Shortchange Select Medical Shareholders?
PHILADELPHIA, March 25, 2026 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is continuing to investigate the fairness of the $16.50 per...
HOLX vs. ALGN: Which MedTech Stock Is the Better Investment Pick Now?
Align Technology's growth surges on record aligner demand and DSO expansion, while Hologic's near-complete buyout leaves little upside for investors.
HOLX vs. ALGN: Which MedTech Stock Is the Better Investment Pick Now?
Align Technology's growth surges on record aligner demand and DSO expansion, while Hologic's near-complete buyout leaves little upside for investors.
📰
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims
ImmunityBio stock sinks 21% after the FDA flags misleading claims on cancer drug Anktiva, citing exaggerated benefits and inadequate risk disclosures.
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims
ImmunityBio stock sinks 21% after the FDA flags misleading claims on cancer drug Anktiva, citing exaggerated benefits and inadequate risk disclosures.
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims
ImmunityBio stock sinks 21% after the FDA flags misleading claims on cancer drug Anktiva, citing exaggerated benefits and inadequate risk disclosures.
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?
ZBH leans on knee growth, robotics innovation and steady markets, but debt levels and stiff competition complicate its near-term investment appeal.
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?
ZBH leans on knee growth, robotics innovation and steady markets, but debt levels and stiff competition complicate its near-term investment appeal.
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?
ZBH leans on knee growth, robotics innovation and steady markets, but debt levels and stiff competition complicate its near-term investment appeal.